Mechanism
Mutant NPM1 (dNPM1 peptides)
Assets acting on this target.
- Class
- Autologous TCR-T cell therapy (lentiviral-engineered)
- Pathway
- T-cell receptor recognition of dNPM1 neoantigen peptides presented on leukemic cells
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.